Stephen A. Moglia, VP, Chief Accounting Officer at Orexigen Therapeutics, Inc. (OREX), sold 800 shares at $1.96 ($2K) on 2016-12-19, disclosed to the SEC on 2016-12-21.
Open-market sale of $2k OREX by VP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.